Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
ABVC BioPharma, Inc. (ABVC) had Return on Investments of -22.68% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-2.77M |
|
-- |
|
-- |
|
$2.20M |
|
$-2.20M |
|
$-0.82M |
|
$-3.02M |
|
$-2.15M |
|
$-3.02M |
|
$-3.02M |
|
$-3.02M |
|
$-2.15M |
|
$-2.20M |
|
$-1.98M |
|
20.11M |
|
20.11M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$2.50M |
|
$12.84M |
|
$18.56M |
|
$21.06M |
|
$6.16M |
|
-- |
|
$1.60M |
|
$7.76M |
|
$13.30M |
|
$13.30M |
|
$13.30M |
|
24.32M |
|
| Cash Flow Statement Financials | |
$-2.99M |
|
$-1.21M |
|
$4.64M |
|
$0.86M |
|
$1.33M |
|
$0.46M |
|
$4.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.41 |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.99M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-22.68% |
|
-22.68% |
|
-14.32% |
|
|
Return on Investments |
-22.68% |
$0.55 |
|
$-0.15 |
|
$-0.15 |
|